blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3572092

EP3572092 - RECOMBINANT GALLID HERPESVIRUS 3 (MDV SEROTYPE 2) VECTORS EXPRESSING ANTIGENS OF AVIAN PATHOGENS AND USES THEREOF [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  01.12.2022
Database last updated on 14.09.2024
FormerRequest for examination was made
Status updated on  29.05.2020
FormerThe application has been published
Status updated on  25.10.2019
Most recent event   Tooltip24.11.2023New entry: Renewal fee paid 
Applicant(s)For all designated states
Boehringer Ingelheim Animal Health USA Inc.
3239 Satellite Boulevard, Bldg. 500
Duluth, GA 30096 / US
[2019/48]
Inventor(s)01 / BUBLOT, Michel
3 Rue Favre Garin
69630 Chaponost / FR
02 / MEBATSION, Teshome
2670 Bent Tree Lane
Watkinsville, GA 30677 / US
03 / PRITCHARD, Joyce
3804 Princeton Court
Gainesville, GA 30504 / US
04 / LINZ, Perry
2286 Cotton Gin Row
Jefferson, GA 30549 / US
 [2019/48]
Representative(s)D Young & Co LLP
3 Noble Street
London EC2V 7BQ / GB
[N/P]
Former [2019/48]D Young & Co LLP
120 Holborn
London EC1N 2DY / GB
Application number, filing date19167408.429.11.2012
[2019/48]
Priority number, dateUS201161564877P30.11.2011         Original published format: US 201161564877 P
US201261694957P30.08.2012         Original published format: US 201261694957 P
[2019/48]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3572092
Date:27.11.2019
Language:EN
[2019/48]
Search report(s)(Supplementary) European search report - dispatched on:EP29.10.2019
ClassificationIPC:A61K39/12
[2019/48]
CPC:
A61K39/12 (EP,CN); C12N15/869 (RU); A61K39/15 (RU);
A61K39/17 (RU); A61K39/255 (RU); A61K39/295 (RU);
A61P31/12 (EP); C07K14/03 (RU); C07K14/125 (RU);
C07K14/14 (RU); C12N15/63 (RU); C12N15/86 (CN);
A61K2039/5256 (EP,CN); A61K2039/54 (EP); A61K2039/552 (EP);
A61K2039/70 (EP,CN); C12N2710/16034 (EP); C12N2710/16041 (EP);
C12N2710/16043 (CN); C12N2710/16071 (EP); C12N2710/16343 (EP);
C12N2720/00034 (EP); C12N2720/10034 (EP,CN); C12N2760/18134 (EP,CN) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/27]
Former [2019/48]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
Extension statesBANot yet paid
MENot yet paid
TitleGerman:REKOMBINANTE GALLID-HERPESVIRUS 3 (MDV-SEROTYP 2)-VEKTOREN, DIE ANTIGENE VON GEFLÜGELPATHOGENEN EXPRIMIEREN UND DEREN VERWENDUNGEN[2019/48]
English:RECOMBINANT GALLID HERPESVIRUS 3 (MDV SEROTYPE 2) VECTORS EXPRESSING ANTIGENS OF AVIAN PATHOGENS AND USES THEREOF[2019/48]
French:VECTEURS RECOMBINANTS DE GALLID HERPÈSVIRUS 3 (MDV SÉROTYPE 2) EXPRIMANT DES ANTIGÈNES DE PATHOGÈNES AVIAIRES ET LEURS UTILISATIONS[2023/40]
Former [2023/40]VECTEURS RECOMBINANTS DE GALLID HERPÈSVIRUS 3 (MDV SÉROTYPE 2) EXPRIMANT DES ANTIGÈNES DE PATHOGÈNES AVIAIRES ET LEURS UTILISATIONS
Examination procedure07.05.2020Amendment by applicant (claims and/or description)
27.05.2020Examination requested  [2020/27]
27.05.2020Date on which the examining division has become responsible
30.11.2022Despatch of a communication from the examining division (Time limit: M06)
04.07.2023Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
04.08.2023Reply to a communication from the examining division
Parent application(s)   TooltipEP12801680.5  / EP2785373
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
21.08.2023Request for further processing filed
21.08.2023Full payment received (date of receipt of payment)
Request granted
30.08.2023Decision despatched
Fees paidRenewal fee
04.04.2019Renewal fee patent year 03
04.04.2019Renewal fee patent year 04
04.04.2019Renewal fee patent year 05
04.04.2019Renewal fee patent year 06
04.04.2019Renewal fee patent year 07
27.11.2019Renewal fee patent year 08
27.11.2020Renewal fee patent year 09
24.11.2021Renewal fee patent year 10
24.11.2022Renewal fee patent year 11
24.11.2023Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XI]KR20010095727  (REP KR NAT VETERINARY RESEARCH [KR]) [X] 1 * the whole document * [I] 2-15;
 [XI]KR20010095727  (REP KR NAT VETERINARY RESEARCH [KR]) [X] 1 * Google and human translations of KR 2001 0095727 * [I] 2-15;
 [XI]EP1298139  (ZEON CORP [JP]) [X] 1 * paragraph [0019] - paragraph [0020] * * paragraph [0022] * * paragraph [0027] * * paragraph [0018] * * paragraph [0021] * * paragraph [0024] * * paragraph [0005] * * examples 6, 7 * [I] 2-10;
 [YD]  - WITTER R L ET AL, "POLYVALENT MAREKS DISEASE VACCINES SAFETY EFFICACY AND PROTECTIVE SYNERGISM IN CHICKENS WITH MATERNAL ANTIBODIES", AVIAN PATHOLOGY, (1984), vol. 13, no. 1, ISSN 0307-9457, pages 75 - 92, XP002794879 [YD] 10-15 * abstract * * table 9 *

DOI:   http://dx.doi.org/10.1080/03079458408418510
 [Y]  - BUBLOT ET AL, "Use of a Vectored Vaccine against Infectious Bursal Disease of Chickens in the Face of High-Titred Maternally Derived Antibody", JOURNAL OF COMPARATIVE PATHOLOGY, ACADEMIC PRESS, LONDON, GB, (20070628), vol. 137, doi:10.1016/J.JCPA.2007.04.017, ISSN 0021-9975, pages S81 - S84, XP022128831 [Y] 10-15 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.jcpa.2007.04.017
 [A]  - PETHERBRIDGE L ET AL, "Cloning of Gallid herpesvirus 3 (Marek's disease virus serotype-2) genome as infectious bacterial artificial chromosomes for analysis of viral gene functions", JOURNAL OF VIROLOGICAL METHODS, ELSEVIER BV, NL, vol. 158, no. 1-2, doi:10.1016/J.JVIROMET.2009.01.009, ISSN 0166-0934, (20090601), pages 11 - 17, (20090131), XP026022528 [A] 1-15 * page 13, column l, paragraph 2 * * page 11, column r, line 7 - line 11 *

DOI:   http://dx.doi.org/10.1016/j.jviromet.2009.01.009
 [A]  - SLACUM ET AL, "The compatibility of HVT recombinants with other Marek's disease vaccines", 58TH WESTERN POULTRY DISEASE CONFERENCE, SACRAMENTO, CA, USA, MARCH 23-25 2009,, (20090101), page 84, XP009167868 [A] 1-15 * abstract *
by applicantUS13689572
 WO8704463
 EP0517292
 US5187087
 US5650153
 WO9816247
 US5853733
 US5980906
 US5980912
 US6183753
 US6299882
 US6866852
    - BUBLOT et al., J.Comp. Path., (20070000), vol. 137, pages S81 - S84
    - MORGAN et al., Avian dis., (19920000), vol. 36, pages 858 - 70
    - JOHNSON et al., Avian Dis, (20100000), vol. 54, pages 1251 - 1259
    - SLACUM G; HEIN R; LYNCH P., "The compatibility of HVT recombinants with other Marek's disease vaccines", Western Poultry Disease Conference, (20090000), page 84, XP009167868
    - PETHERBRIDGE et al., J. Virol. Methods, (20090000), vol. 158, pages 11 - 17
    - SINGH et al., Research in Veterinary Science, (20100000), vol. 89, pages 140 - 145
    - SPATZ; SCHAT, Virus Gene, (20110000), vol. 42, pages 331 - 338
    - IGARASHI T. et al., J. Gen. Virol., (19890000), vol. 70, pages 1789 - 1804
    - "GenBank", Database accession no. HQ840738.1
    - PONTAROLLO R.A. et al., Vet. Immunol. Immunopath, (20020000), vol. 84, pages 43 - 59
    - WERNETTE C.M. et al., Vet. Immunol. Immunopath, (20020000), vol. 84, pages 223 - 236
    - MUTWIRI G. et al., Vet. Immunol. Immunopath, (20030000), vol. 91, pages 89 - 103
    - "Vaccine Design The Subunit and Adjuvant Approach", Pharmaceutical Biotechnology, vol. 6, page 3,157
    - M. POWELL; M. NEWMAN, Vaccine Design, The Subunit and Adjuvant Approach, Plenum Press, (19950000), page 147
    - WISE et al., "Development of a Real-Time Reverse-Transcription PCR for Detection of Newcastle Disease Virus RNA in Clinical Samples", J Clin Microbiol, (20040000), vol. 42, pages 329 - 338
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.